Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
JAMA Ophthalmology Author Interviews9 Jan 2012

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
svd-nyhetsartiklar
kapitalet-en-podd-om-ekonomi
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-vetenskapsradion-2
dumforklarat
sexet
rss-ufo-bortom-rimligt-tvivel-2
rss-odla
medicinvetarna
hacka-livet
barnpsykologerna
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
halsorevolutionen
paranormalt-med-caroline-giertz
vetenskapsradion